Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | POLA1 | P09884 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 5/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 5/20 | 0.35 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.35 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.35 |
| ▸ | CDK7 | P50613 | 1/20 | 0.35 |
| ▸ | CDK9 | P50750 | 1/20 | 0.35 |
| ▸ | CCNH | P51946 | 1/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.33 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27568676 | 0.90 | POLA1 (0.56) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| SCHEMBL3691693 | 0.88 | POLA1 (0.51) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| SCHEMBL5138814 | 0.85 | ALDH1A1 (0.53) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| SCHEMBL5482507 | 0.83 | ALDH1A1 (0.47) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| SCHEMBL28231112 | 0.82 | ALDH1A1 (0.50) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| SCHEMBL27658630 | 0.82 | ALDH1A1 (0.50) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| SCHEMBL28418915 | 0.82 | POLA1 (0.46) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| SCHEMBL28252480 | 0.81 | ALDH1A1 (0.46) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| SCHEMBL27747326 | 0.81 | ALDH1A1 (0.46) | ALDH1A1KDM4EPOLA1CDK2RXFP1 | |
| Iodide SCHEMBL28673351 | 0.81 | ALDH1A1 (0.53) | ALDH1A1KDM4EPOLA1CDK2RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4169717-A | METAL PROTEINATE AND GROWTH HORMONE | ASHMEAD H H | 1979-10-02 | — | — | US | claimed |
| EP-4137500-B1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL CO (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-12540156-B2 | Method for producing nucleic acid oligomer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2026-02-03 | — | — | US | disclosed |
| US-12377409-B2 | Inorganic porous carrier, and production method for nucleic acid using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-08-05 | — | — | US | disclosed |
| US-12378275-B2 | Porous inorganic carrier and method for producing nucleic acid using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-08-05 | — | — | US | disclosed |
| US-12371451-B2 | Inorganic porous carrier and method for producing nucleic acids using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-07-29 | — | — | US | disclosed |
| CN-115362163-B | Method for producing nucleic acid oligomer | 住友化学株式会社 | 2025-04-11 | — | — | CN | disclosed |
| US-12173022-B2 | Method for producing RNA | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-12-24 | — | — | US | disclosed |
| US-12162765-B2 | Inorganic porous support and method for producing nucleic acid using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-12-10 | — | — | US | disclosed |
| US-20240300993-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-09-12 | — | — | US | disclosed |
| CN-113677432-A | Inorganic porous support and method for producing nucleic acid using same | 住友化学株式会社 | 2021-11-19 | — | — | CN | disclosed |
| CN-113646083-A | Inorganic porous support and method for producing nucleic acid using same | 住友化学株式会社 | 2021-11-12 | — | — | CN | disclosed |
| CN-113631264-A | Inorganic porous support and method for producing nucleic acid using same | 住友化学株式会社 | 2021-11-09 | — | — | CN | disclosed |
| CN-113631265-A | Inorganic porous support and method for producing nucleic acid using same | 住友化学株式会社 | 2021-11-09 | — | — | CN | disclosed |
| WO-2020202951-A1 | POROUS INORGANIC CARRIER AND METHOD FOR PRODUCING NUCLEIC ACID USING SAME | 住友化学株式会社 | 2020-10-08 | — | — | WO | disclosed |
| WO-2020202952-A1 | INORGANIC POROUS CARRIER, AND PRODUCTION METHOD FOR NUCLEIC ACID USING SAME | 住友化学株式会社 | 2020-10-08 | — | — | WO | disclosed |
| WO-2020202950-A1 | INORGANIC POROUS CARRIER AND METHOD FOR PRODUCING NUCLEIC ACIDS USING SAME | 住友化学株式会社 | 2020-10-08 | — | — | WO | disclosed |
| WO-2020202953-A1 | INORGANIC POROUS SUPPORT AND METHOD FOR PRODUCING NUCLEIC ACID USING SAME | 住友化学株式会社 | 2020-10-08 | — | — | WO | disclosed |
| CN-104936959-B | 2,6, 9-trisubstituted purine derivative and preparation method and application thereof | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 2018-09-18 | — | — | CN | disclosed |
| US-4470840-A | WITH SOLVENT, COMPOUNDS 2A,2B,3, AND 4, AND PLANT GROWTH REGULATOR | BIOCHEMICAL RESEARCH CORPORATION (US) | 1984-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12371451-B2 | Inorganic porous carrier and method for producing nucleic acids using same | SLCO2A1, SLCO2B1, SLCO4C1 | ALDH1A1 2736/4885KDM4E 2698/4885POLA1 66/4885 |
| US-20240300993-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | NSUN3, NSUN2, NOP2 | ALDH1A1 2651/4885KDM4E 4122/4885POLA1 35/4885 |
| US-12173022-B2 | Method for producing RNA | NSUN3, NSUN2, RNMT | ALDH1A1 3532/4885KDM4E 3538/4885POLA1 227/4885 |
| US-12540156-B2 | Method for producing nucleic acid oligomer | NSUN2, RNGTT, RNMT | ALDH1A1 3731/4885KDM4E 2585/4885POLA1 74/4885 |
| US-12378275-B2 | Porous inorganic carrier and method for producing nucleic acid using same | SLCO2A1, SLCO2B1, SLCO1A2 | ALDH1A1 2385/4885KDM4E 2653/4885POLA1 36/4885 |
| US-12377409-B2 | Inorganic porous carrier, and production method for nucleic acid using same | SLCO2A1, SLCO2B1, SLCO1A2 | ALDH1A1 2280/4885KDM4E 2411/4885POLA1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.